According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial ...
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN ...
Researchers at TU Wien are developing a model that interprets opinions not as diametrically opposed poles, but as overlapping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback